A bayesian meta-analysis comparing AngioJet® thrombectomy to percutaneous coronary intervention alone in acute myocardial infarction

Journal of Interventional Cardiology

Volumn 21, Issue 6, 2008, Pages 459-482

  Grines, Cindy L ^a,c   Nelson, Teresa R ^b   Safian, Robert D ^a   Hanzel, George ^a   Goldstein, James A ^a   Dixon, Simon ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b Technomics Research LLC   (United States)

^c Possis Inc

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ENOXAPARIN; PLACEBO; RAPAMYCIN; TENECTEPLASE;

ACUTE HEART INFARCTION; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CLINICAL TRIAL; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; RHEOLYTIC THROMBECTOMY; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; THROMBUS; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BAYES THEOREM; HUMANS; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STENTS; THROMBECTOMY; TREATMENT OUTCOME;

EID: 56549099146     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2008.00416.x     Document Type: Article

References (105)

1. Ali A, Cox D, Dib N, et al. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. J Am Coll Cardiol 2006 48 : 244 252.
2. Speigelhalter D, Abrams K, Myles J. Evidence synthesis. In : Senn S, Barrett V, eds. Bayesian Approaches to Clinical Trials and Health-Care Evaluation. John Wiley & Sons Ltd., 2004, pp. 267 303.
3. Prevost T, Abrams K, Jones D. Hierarchical models in generalized synthesis of evidence: An example based on studies of breast cancer screening. Stat Med 2000 19 : 3359 3376.
4. Antoniucci D, Valenti R, Migliorini A, et al. Comparison of rheolytic thrombectomy before direct infarct artery stenting versus direct stenting alone in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 2004 93 : 1033 1035.
5. DeLago A, Papaleo R, Macina A, et al. Initial experience with AngioJet mechanical thrombectomy in the treatment of acute myocardial Infarction (poster). Albany Medical Center. Albany, NY. Presented at American College of Cardiology 2000. J Am Coll Cardiol 2000 35 (Suppl. A 19A.
6. Margheri M, Falai M, Vittori G, et al. Safety and efficacy of the AngioJet in patients with acute myocardial infarction: Results from the Florence appraisal study of rheolytic thrombectomy (FAST). J Invasive Cardiol 2006 18 : 481 486.
7. Sianos G, Papafaklis M, Vaina S, et al. Rheolytic thrombectomy in patients with ST-elevation myocardial infarction and large thrombus burden: The Thoraxcenter experience. J Invasive Cadiol 1006 18 (Suppl. 3C 7C.
8. Sharma S, Tamburrino F, Mares A, Kini A. Improved outcome with AngioJet thrombectomy during primary stenting in acute myocardial infarction in patients with high-grade thrombus. J Invasive Cardiol 2006 18 (Suppl. 8C 11C.
9. Sherev DA, Shavelle DM, Abdelkarim M, et al. AngioJet Rheolytic thrombectomy during rescue PCI for failed thrombolysis: A single-center experience. J Invasive Cardiol 2006 : 18 (Suppl. C 12C 16C.
10. Chinnaiyan KM, Grines CL, O'Neill WW, et al. Safety of AngioJet thrombectomy in acute ST-segment elevation myocardial infarction: A large, single-center experience. J Invasive Cardiol 2006 Suppl. C 17C 21C.
11. Nakagawa Y, Matsuo S, Kimura T, et al. Thrombectomy with AngioJet catheter in native coronary arteries for patients with acute or recent myocardial infarction. Am J Cardiol 1999 83 : 994 999.
12. AngioJet Premarket approval available at the FDA. Available at : http://www.fda.gov/cdrh/pdf/P980037.html. Accessed May 20, 2008.
13. Antoniucci D, Rodriguez A, Hempel A, et al. A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction. J Am Coll Cardiol 2003 42 : 1879 1885.
14. Antoniucci D, Migliorini A, Parodi G, et al. Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival: A prospective, multicenter, randomized trial comparing infarct artery stenting plus abciximab with stenting alone. Circulation 2004 109 : 1704 1706.
15. Montalescot G, Barragan P, Wittenberg O, et al. Abciximab before direct angioplasty and stenting in myocardial infarction regarding acute and long-term follow-up. Platelet glycoprotein llb/llla inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001 344 : 1895 1903.
16. Advance MI Investigators. Facilitated percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: Results from the prematurely terminated addressing the value of facilitated angioplasty after combination therapy or eptifibatide monotherapy in acute myocardial infarction (Advance MI) trial. Am Heart J 2005 150 : 116 122. Erratum in: Am Heart J 2005;150:391.
17. Grines CL, Westerhausen DR, Grines LL, et al. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: The air primary angioplasty in myocardial infarction study. J Am Coll Cardiol 2002 39 : 1713 1719.
18. APEX AMI Investigators, Armstrong PW, Granger CB, et al. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: A randomized controlled trial. JAMA 2007 297 : 43 51.
19. ASSENT-4 PCI Investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): Randomised trial. Lancet 2006 367 : 569 578.
20. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomized trials. Lancet 2003 361 : 13 20.
21. Bellandi F, Maioli M, Leoncini M, et al. Early abciximab administration in acute myocardial infarction treated with primary coronary intervention. Int J Cardiol 2006 108 : 36 42.
22. Berrocal DH, Cohen MG, Apinetta AD, et al. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase. Am Heart J 2003 146 : E22.
23. Kastrati A, Mehilli J, Schlotterbeck K, et al. Early administration of reteplase plus abciximab versus abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: A randomized controlled trial. JAMA 2004 291 : 947 954.
24. Stone GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002 346 : 957 966.
25. Le May MR, Wells GA, Labinaz M, et al. Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (Capital AMI study). J Am Coll Cardiol 2005 46 : 417 424.
26. Bonnefoy E, Lapostolle F, Leizorovicz A, et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: A randomized study. Lancet 2002 360 : 825 829.
27. Bar FW, Tzivoni D, Dirksen MT, et al. Results of the first clinical study of adjunctive caldaret (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: The randomized multicentre CASTEMI study. Eur Heart J 2006 27 : 2516 2523.
28. Inoue T, Yaguchi I, Takayanagi K, et al. A new thrombolytic agent, monteplase, is independent of the plasminogen activator inhibitor in patients with acute myocardial infarction: Initial results of the combining monteplase with angioplasty (COMA) trial. Am Heart J 2002 144 : E5.
29. Granger CB, Mahaffey KW, Weaver WD, et al. Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: The complement inhibition in myocardial infarction treated with angioplasty (COMMA) trial. Circulation 2003 108 : 1184 1190.
30. Aversano T, Aversano LT, Passamani E, et al. Thomblytic therapy vs. primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: A randomized controlled trial. JAMA 2002 287 : 1943 1951. Erratum in: JAMA 2002;287:3212.
31. Cutlip DE, Ricciardi MJ, Ling FS, et al. Effect of tirofiban before primary angioplasty on initial coronary flow and early ST-segment resolution in patients with acute myocardial infarction. Am J Cardiol 2003 92 : 977 980.
32. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003 349 : 733 742.
33. De Luca L, Sardella G, Davidson CJ, et al. Impact of intracoronary aspiration thrombectomy during primary angioplasty on left ventricular remodeling in patients with anterior ST elevation myocardial infarction. Heart 2006 92 : 951 957.
34. Silva-Orrego P, Colombo P, Bigi R, et al. Thrombus aspiration before primary angioplasty improves myocardial reperfusion in acute myocardial infarction: The DEAR-MI (dethrombosis to enhance acute reperfusion in myocardial infarction) study. J Am Coll Cardiol 2006 48 : 1552 1559.
35. Dixon SR, Whitbourn RJ, Dae MW, et al. Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol 2002 40 : 1928 1934.
36. Dobrzycki S, Mezynski G, Kralisz P, et al. Is transport with platelet GP llb/llla inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomized study. Early results. Kardiol Pol 2006 64 : 793 799.
37. Dudek D, Mielecki W, Legutko J, et al. Percutaneous thrombectomy with the RESCUE system in acute myocardial infarction. Kardiol Pol 2004 61 : 523 533.
38. Stone GW, Webb J, Cox DA, et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: A randomized controlled trial. JAMA 2005 293 : 1063 1072.
39. Emre A, Ucer E, Yesilciment K, et al. Impact of early tirofiban administration on myocardial salvage in patients with acute myocardial infarction undergoing infarct-related artery stenting. Cardiology 2006 106 : 264 269.
40. Gabriel HM, Oliveira JA, da Silva PC, da Costa JM, da Cunha JA. Early administration of abciximab bolus in the emergency department improves angiographic outcome after primary PCI as assessed by TIMI frame count: Results of the early ReoPro administration in myocardial infarction (ERAMI) trial. Catheter Cardiovasc Interv 2006 68 : 218 224.
41. Garcia E, Elizaga J, Perez-Castellano N, et al. Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction. J Am Coll Cardiol 1999 33 : 605 611.
42. Fernandez-Aviles F, Alonso JJ, Castro-Beiras A, et al. Routine invasive strategy within 24 hours of thrombolysis versus ischemia-guided conservative approach for acute myocardial infarction with ST-segment. Lancet 2004 364 : 1045 1053.
43. Faxon DP, Givvons RJ, Chronos NA, et al. The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: The results of the HALT-MI study. J Am Coll Cardiol 2002 40 : 1199 1204.
44. Hara M, Saikawa T, Tsunematsu Y, et al. Predicting no-reflow based on angiographic features of lesions in patients with acute myocardial infarction. J Atheroscler Thromb 2005 12 : 315 321.
45. Liem A, Zijlstra F, Ottervanger JP, et al. High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: The heparin in early patency (HEAP) randomized trial. J Am Coll Cardiol 2000 35 : 600 604.
46. Dieker HJ, van Horssen EV, Hersbach FM, et al. Transport for abciximab facilitated primary angioplasty versus on-site thrombolysis with a liberal rescue policy: The randomized Holland infarction study (HIS). J Thromb Thrombolysis 2006 22 : 39 45.
47. Zeymer U, Zahn R, Schiele R, et al. Early eptifibatide improves TIMI 3 patency before primary percutaneous coronary intervention for acute ST elevation myocardial infarction: Results of the randomized integrilin in acute myocardial infarction (INTAMI) pilot trial. Eur Heart J 2005 26 : 1971 1977.
48. Kaltoft A, Bottcher M, Nielsen SS, et al. Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: A randomized, controlled trial. Circulation 2006 114 : 40 47.
49. Kimura K, Tsukahara K, Usui T, et al. Low-dose tissue plasminogen activator followed by planned rescue angioplasty reduces time to reperfusion for acute myocardial infarction treated at community hospitals. Jpn Circ J 2001 65 : 901 906.
50. Loubeyre C, Morice MC, Lefevre T, et al. A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction. J Am Coll Cardiol 2002 39 : 15 21.
51. Marenzi G, Assanelli E, Marana I, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006 354 : 2773 2782.
52. Sutton AG, Campbell PG, Graham R, et al. One-year results of the Middlesbrough early revascularization to limit infarction (MERLIN) trial. Heart 2005 91 : 1330 1337.
53. Sutton AG, Campbell PG, Graham R, et al. A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: The Middlesbrough early revascularization to limit infarction (MERLIN) trial. J Am Coll Cardiol 2004 44 : 287 296.
54. Nakashima H, Katayama T, Honda Y, et al. Cardioprotective effects of magnesium sulfate in patients undergoing primary coronary angioplasty for acute myocardial infarction. Circ J 2004 68 : 23 28.
55. Napodano M, Pasquetto G, Sacca S, et al. Intracoronary thrombectomy improves myocardial reperfusion in patients undergoing direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 2003 42 : 1395 1402.
56. Ochiai M, Eto K, Takeshita S, et al. Impact of cilostazol on clinical and angiographic outcome after primary stenting for acute myocardial infarction. Am J Cardiol 1999 84 : 1074 1076, A6, A9.
57. van't Hof AW, Ernst N, de Boer MJ, et al. Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: Results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial. Eur Heart J 2004 25 : 837 846.
58. Ozdemir R, Sezgin AT, Barutcu I, et al. Comparison of direct stenting versus conventional stent implantation on blood flow in patients with ST-segment elevation myocardial infarction. Angiology 2006 57 : 453 458.
59. Ross AM, Coyne KS, Reiner JS, et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: The PACT investigators. Plasminogen-activator angioplasty compatibility trial. J Am Coll Cardiol 1999 34 : 1954 1962.
60. Laarman GJ, Suttorp MJ, Dirksen MT, et al. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 2006 355 : 1105 1113.
61. Saito S, Hosokawa G, Tanaka S, et al. Primary stent implantation is superior to balloon angioplasty in acute myocardial infarction: Final results of the primary angioplasty versus stent implantation in acute myocardial infarction (PASTA) trial. PASTA trial investigators. Catheter Cardiovasc Interv 1999 48 : 262 268.
62. Petronio AS, Musumeci G, Limbruno U, et al. Abciximab improves 6-month clinical outcome after rescue coronary angioplasty. Am Heart J 2002 143 : 334 341.
63. Widimsky P, Budesinksy T, Vorac D, et al. Long distance transport for primary angioplasty vs. immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial - PRAGUE-2. Eur Heart J 2003 24 : 94 104.
64. Widimsky P, Groch L, Zelizko M, et al. Multicentre randomized trial comparing transport to primary angioplasty vs. immediate thrombolysis versus combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J 2000 21 : 823 831.
65. Bednar F, Widimsky P, Krupicka J, et al. Interhospital transport for primary angioplasty improves the long-term outcome of acute myocardial infarction compared with immediate thrombolysis in the nearest hospital (one-year follow-up of the PRAGUE-1 study). Can J Cardiol 2003 19 : 1133 1137.
66. Scheller B, Hennen B, Severin-Kneib S, et al. Long-term follow-up of a randomized study of primary stenting versus angioplasty in acute myocardial infarction. Am J Med 2001 110 : 1 6.
67. Cantor WJ, Puley G, Natarajan MK, et al. Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein llb/llla inhibition in acute myocardial infarction - the RADIAL-AMI pilot randomized trial. Am Heart J 2005 150 : 543 549.
68. Burzotta F, Trani C, Romagnoli E, et al. Manual thrombus-aspiration improves myocardial reperfusion: The randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial. J Am Coll Cardiol 2005 46 : 371 376.
69. Gyongyosi M, Domanovits H, Benzer W, et al. Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion - results of the Austrian multi-centre randomized ReoPro-BRIDGING study. Eur Heart J 2004 25 : 2125 2133.
70. Ellis SG, Da Silva ER, Spaulding CM, et al. Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: Insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences. Am Heart J 2000 139 : 1046 1053.
71. Patel TN, Bavry AA, Kumbhani DJ, et al. A meta-analysis of randomized trials of rescue percutaneous coronary intervention after failed fibrinolysis. Am J Cardiol 2006 97 : 1685 1690.
72. Santoro GM, Antoniucci D, Bolognese L, et al. A randomized study of intravenous magnesium in acute myocardial infarction treated with direct coronary angioplasty. Am Heart J 2000 140 : 891 897.
73. Scheller B, Hennen B, Hammer B, et al. Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. J Am Coll Cardiol 2003 42 : 634 641.
74. Le May MR, Labinaz M, Davies RF, et al. Stenting versus thrombolysis in acute myocardial infarction trial (STAT). J Am Coll Cardiol 2001 37 : 985 991.
75. Grines CL, Cox DA, Stone GW, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent primary angioplasty in myocardial infarction study group. N Engl J Med 1999 341 : 1949 1956.
76. Maillard L, Hamon M, Khalife K, et al. A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. STENTIM-2 investigators. J Am Coll Cardiol 2000 35 : 1729 1736.
77. Schomig A, Kastrati A, Dirschinger J, et al. Coronary stenting plus platelet glycoprotein llb/llla blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus thrombolysis for occluded coronary arteries in patients with acute myocardial infarction study investigators. N Engl J Med 2000 343 : 385 391.
78. Schomig A, Ndrepepa G, Mehilli J, et al. A randomized trial of coronary stenting versus balloon angioplasty as a rescue intervention after failed thrombolysis in patients with acute myocardial infarction. J Am Coll Cardiol. 2004 44 : 2073 2079.
79. Valgimigli M, Percoco G, Malagutti P, et al. Tirofiban and sirolimus-eluting stent vs. abciximab and bare-metal stent for acute myocardial infarction: A randomized trial. JAMA 2005 293 : 2109 2117.
80. Suryapranata H, Ottervanger JP, Nivvering E, et al. Long-term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarction. Heart 2001 85 : 667 671.
81. Suryapranata H, De Luca G, van 't Hof AW, et al. Is routine stenting for acute myocardial infarction superior to balloon angioplasty? A randomized comparison in a large cohort of unselected patients. Heart 2005 91 : 641 645.
82. Svensson L, Aasa M, Dellborg M, et al. Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery epicardial flow in patients with acute ST-segment elevation myocardial infarction: The Swedish early decision (SWEDES) reperfusion trial. Am Heart J 2006 151 : 798.e1 7.
83. Saito S, Tanaka S, Hiroe Y, et al. Comparative study on transradial approach vs. transfemoral approach in primary stent implantation for patients with acute myocardial infarction: Results of the test for myocardial infarction by prospective unicenter randomization for access sites (TEMPURA) trial. Catheter Cardiovasc Interv 2003 59 : 26 33.
84. Thiele H, Engelmann L, Elsner K, et al. Comparison of pre-hospital combination-fibrinolysis plus conventional care with pre-hospital combination-fibrinolysis plus facilitated percutaneous coronary intervention in acute myocardial infarction. Eur Heart J 2005 26 : 1956 1963.
85. Thiele H, Scholz M, Englemann L, et al. ST-segment recovery and prognosis in patients with ST-elevation myocardial infarction reperfused by prehospital combination fibrinolysis, prehospital initiated facilitated percutaneous coronary intervention, or primary percutaneous coronary intervention. Am J Cardiol 2006 98 : 1132 1139.
86. Lee DP, Herity NA, Hiatt BL, et al. Adjunctive platelet glycoprotein llb/llla receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes: Results of the tirofiban given in the emergency room before primary angioplasty (TIGER-PA) pilot trial. Circulation 2003 107 : 1497 1501.
87. Gibson CM, Kirtane AJ, Murphy SA, et al. Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Results of the time to integrilin therapy in acute myocardial infarction (TITAN)-TIMI 34 trial. Am Heart J 2006 152 : 668 678.
88. Spaulding C, Henry P, Teiger E, et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 355 : 1093 1104.
89. Van der Horst IC, Zijlstra F, van't Hof AW, et al. Glucose-insulin- potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: The glucose-insulin-potassium study: A randomized trial. J Am Coll Cardiol 2003 42 : 784 791.
90. Van der Horst IC, Ottervanger JP, van't Hof AW, et al. The impact of glucose-insulin-potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction [ISRCTN56720616]. BMC Med 2005 3 : 9.
91. Vermeer F, Oude Ophuis AJ, vd Berg EJ, et al. Prospective randomized comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: A safety and feasibility study. Heart 1999 82 : 426 431.
92. Lefevre T, Garcia E, Reimers B, et al. X-sizer for thrombectomy in acute myocardial infarction improves ST-segment resolution: Results of the X-sizer in AMI for negligible embolization and optimal ST resolution (X AMINE ST) trial. J Am Coll Cardiol 2005 46 : 246 252.
93. Zhang D, Cai X, Zhang R, et al. Primary intracoronary stenting in comparison with intravenous rt-PA thrombolysis plus rescue intracoronary intervention in patients with acute myocardial infarction. Chin Med J 2002 115 : 163 165.
94. Zorman S, Zorman D, Noc M. Effects of abciximab pretreatment in patients with acute myocardial infarction undergoing primary angioplasty. Am J Cardiol 2002 90 : 533 536.
95. De Luca G, Suryapranata H, van't Hof AW, et al. Impact of routine stenting on myocardial perfusion and the extent of myocardial necrosis in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. Am Heart J 2006 151 : 1296. e1 e6.
96. Zijlstra F, Hoorntje JC, de Boer MJ, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med, 1999 341 : 1413 1419.
97. Henriques JP, Zijlstra F, van't Hof AW, et al. Primary percutaneous coronary intervention versus thrombolytic treatment: Long-term follow-up according to infarct location. Heart 2006 92 : 75 79.
98. Gibson C, Cannon C, Murphy S, et al. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation 2002 105 : 1909 1913.
99. Henriques J, Zijlstra F, Ottervanger J, et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 2002 23 : 1112 1117
100. Shah P, Ahmed W, Ganz P, et al. Bivalirudin compared with heparin during coronary angioplasty for thrombus-containing lesions. J Am Coll Cardiol 1997 30 : 1264 1269.
101. Brodie B, Stuckey T, Wall T, et al. Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1998 32 : 1312 1319.
102. De Luca G, Suryapranata H, Ottervanger J, et al. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: Every minute of delay counts. Circulation 2004 109 : 1223 1225.
103. De Luca G, Suryapranata H, Stone GW, et al. Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: A meta-analysis of randomized trials. Am Heart J 2007 153 : 343 353.
104. Svilaas T, Vlaar PJ, van der Horst IC, et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008 358 : 557 567.
105. Sianos G, Papfaklis MI, Daemen J, et al. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: The importance of thrombus burden. J Am Coll Cardiol 2007 50 : 573 583.